首页 > 最新文献

IJID regions最新文献

英文 中文
Navigating Candidemia in a tertiary hospital: A 4-year epidemiologic and clinical review 三级医院念珠菌病的防治:4年流行病学和临床回顾
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-02-19 DOI: 10.1016/j.ijregi.2026.100864
Chadi Hage Chehade , Bassem Habr , Carine Harmouche , May Fakhoury , Nabil Chehata , Hassan Choker , Christian Haddad , Issam Daou , Zeina Bou Chebl , Racha Eid , Elie Haddad

Objectives

This study describes the epidemiology, risk factors, therapeutic management, antifungal resistance patterns, and clinical outcomes of candidemia in hospitalized patients. It also examines predictors of 30-day mortality and factors associated with Candida albicans (CA) vs non-albicans Candida (NCA) infections.

Methods

A retrospective review was conducted at a tertiary care center in Lebanon (2017-2021). Clinical, microbiological, and treatment data were extracted from medical records. Statistical analyses were performed to identify factors associated with 30-day mortality and the occurrence of CA vs NCA species.

Results

A total of 98 candidemia episodes in 93 patients were analyzed. CA and NCA species were equally represented (50% each). Resistance was highest to fluconazole and itraconazole (7.3%). The 30-day mortality rate was 38.8%. Factors significantly associated with increased mortality included intensive care unit admission (odds ratio [OR] 7.42), chronic renal failure (OR 7.29), dialysis (OR 7.28), mechanical ventilation (OR 4.71), and central venous catheters (OR 10.91). Catheter removal was protective (OR 0.205, P = 0.002). NCA infections were associated with dyslipidemia (OR 3.33) and multiple previous hospitalizations (OR 3.65).

Conclusion

Antifungal resistance remains relatively low in this cohort; however, candidemia continues to carry a high mortality rate. Optimizing management through adherence to international guidelines and specialist oversight is essential to improve outcomes and address the diverse clinical presentations of CA and NCA infections.
目的探讨住院患者念珠菌病的流行病学、危险因素、治疗管理、抗真菌耐药模式和临床结果。它还检查了30天死亡率的预测因素以及与白色念珠菌(CA)与非白色念珠菌(NCA)感染相关的因素。方法对黎巴嫩某三级保健中心(2017-2021)进行回顾性分析。从医疗记录中提取临床、微生物学和治疗数据。进行统计分析,以确定与30天死亡率和CA与NCA物种发生相关的因素。结果93例患者共98次念珠菌发作。CA和NCA的比例相等(各占50%)。氟康唑和伊曲康唑耐药率最高(7.3%)。30天死亡率为38.8%。与死亡率增加显著相关的因素包括重症监护病房入住(优势比[OR] 7.42)、慢性肾功能衰竭(OR 7.29)、透析(OR 7.28)、机械通气(OR 4.71)和中心静脉导管(OR 10.91)。拔管具有保护作用(OR 0.205, P = 0.002)。NCA感染与血脂异常(OR 3.33)和多次住院(OR 3.65)相关。结论本组患者抗真菌药物耐药性较低;然而,念珠菌的死亡率仍然很高。通过遵守国际指南和专家监督来优化管理对于改善结果和解决CA和NCA感染的不同临床表现至关重要。
{"title":"Navigating Candidemia in a tertiary hospital: A 4-year epidemiologic and clinical review","authors":"Chadi Hage Chehade ,&nbsp;Bassem Habr ,&nbsp;Carine Harmouche ,&nbsp;May Fakhoury ,&nbsp;Nabil Chehata ,&nbsp;Hassan Choker ,&nbsp;Christian Haddad ,&nbsp;Issam Daou ,&nbsp;Zeina Bou Chebl ,&nbsp;Racha Eid ,&nbsp;Elie Haddad","doi":"10.1016/j.ijregi.2026.100864","DOIUrl":"10.1016/j.ijregi.2026.100864","url":null,"abstract":"<div><h3>Objectives</h3><div>This study describes the epidemiology, risk factors, therapeutic management, antifungal resistance patterns, and clinical outcomes of candidemia in hospitalized patients. It also examines predictors of 30-day mortality and factors associated with <em>Candida albicans</em> (CA) vs non-<em>albicans Candida</em> (NCA) infections.</div></div><div><h3>Methods</h3><div>A retrospective review was conducted at a tertiary care center in Lebanon (2017-2021). Clinical, microbiological, and treatment data were extracted from medical records. Statistical analyses were performed to identify factors associated with 30-day mortality and the occurrence of CA vs NCA species.</div></div><div><h3>Results</h3><div>A total of 98 candidemia episodes in 93 patients were analyzed. CA and NCA species were equally represented (50% each). Resistance was highest to fluconazole and itraconazole (7.3%). The 30-day mortality rate was 38.8%. Factors significantly associated with increased mortality included intensive care unit admission (odds ratio [OR] 7.42), chronic renal failure (OR 7.29), dialysis (OR 7.28), mechanical ventilation (OR 4.71), and central venous catheters (OR 10.91). Catheter removal was protective (OR 0.205, <em>P</em> = 0.002). NCA infections were associated with dyslipidemia (OR 3.33) and multiple previous hospitalizations (OR 3.65).</div></div><div><h3>Conclusion</h3><div>Antifungal resistance remains relatively low in this cohort; however, candidemia continues to carry a high mortality rate. Optimizing management through adherence to international guidelines and specialist oversight is essential to improve outcomes and address the diverse clinical presentations of CA and NCA infections.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100864"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147421067","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determinants of COVID-19 outbreak size in elderly residential facilities in Okinawa Prefecture, Japan, April to June 2022 2022年4月至6月日本冲绳县老年居住设施中COVID-19疫情规模的决定因素
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-11-25 DOI: 10.1016/j.ijregi.2025.100813
Yining S Xu , Yusuke Shimakawa , Gerardo Chowell , Ryota Matsuyama , Tetsuharu Nagamoto , Ryosuke Omori , Takashi Nakamura , Toru Itokazu , Yoshihiro Takayama , Kenji Mizumoto

Objectives

: COVID-19 outbreaks in residential facilities for the elderly can have severe consequences; however, effective preventive strategies remain under-evaluated. This study aimed to identify actionable, facility-level factors associated with outbreak size in such facilities in Okinawa, Japan.

Methods

: We conducted a questionnaire-based cross-sectional study of 78 residential facilities for the elderly that experienced confirmed COVID-19 outbreaks between April and June 2022. Facility-level data on infection-control practices, outbreak characteristics, and staff testing approaches were analyzed using negative binomial regression models to quantify factors associated with outbreak size.

Results

: Outbreaks detected via contact-based testing of staff were significantly smaller than those detected through routine staff reverse transcription polymerase chain reaction screening (adjusted relative risk [aRR]: 0.11; 95% confidence interval [CI]: 0.03-0.37). Resident mask-wearing was associated with smaller outbreak sizes (aRR: 0.40; 95% CI: 0.16-0.99). Routine screening identified only 16.7% of staff index cases despite being widely implemented, suggesting limitations in effectiveness.

Conclusions

: Risk-based, exposure-driven testing appears markedly more effective than fixed-interval screening for limiting outbreak size in residential facilities for the elderly. Implementation should consider both operational feasibility and support systems for frontline staff.
目标:在老年人居住设施中暴发COVID-19可能会产生严重后果;然而,有效的预防战略仍未得到充分评价。本研究旨在确定日本冲绳此类设施中与疫情规模相关的可操作的设施级因素。方法:对2022年4月至6月期间确诊发生COVID-19疫情的78家老年人居住设施进行问卷调查。使用负二项回归模型分析了有关感染控制措施、爆发特征和工作人员检测方法的设施级数据,以量化与爆发规模相关的因素。结果:通过工作人员接触检测发现的疫情明显小于通过常规工作人员逆转录聚合酶链反应筛查发现的疫情(调整相对风险[aRR]: 0.11; 95%可信区间[CI]: 0.03-0.37)。居民佩戴口罩与较小的疫情规模相关(aRR: 0.40; 95% CI: 0.16-0.99)。常规筛查尽管得到广泛实施,但仅发现16.7%的工作人员指标病例,表明其有效性存在局限性。结论:基于风险、暴露驱动的检测在限制老年人居住设施的疫情规模方面明显比固定间隔筛查更有效。实施时应考虑操作的可行性和前线员工的支援系统。
{"title":"Determinants of COVID-19 outbreak size in elderly residential facilities in Okinawa Prefecture, Japan, April to June 2022","authors":"Yining S Xu ,&nbsp;Yusuke Shimakawa ,&nbsp;Gerardo Chowell ,&nbsp;Ryota Matsuyama ,&nbsp;Tetsuharu Nagamoto ,&nbsp;Ryosuke Omori ,&nbsp;Takashi Nakamura ,&nbsp;Toru Itokazu ,&nbsp;Yoshihiro Takayama ,&nbsp;Kenji Mizumoto","doi":"10.1016/j.ijregi.2025.100813","DOIUrl":"10.1016/j.ijregi.2025.100813","url":null,"abstract":"<div><h3>Objectives</h3><div><em>:</em> COVID-19 outbreaks in residential facilities for the elderly can have severe consequences; however, effective preventive strategies remain under-evaluated. This study aimed to identify actionable, facility-level factors associated with outbreak size in such facilities in Okinawa, Japan.</div></div><div><h3>Methods</h3><div><em>:</em> We conducted a questionnaire-based cross-sectional study of 78 residential facilities for the elderly that experienced confirmed COVID-19 outbreaks between April and June 2022. Facility-level data on infection-control practices, outbreak characteristics, and staff testing approaches were analyzed using negative binomial regression models to quantify factors associated with outbreak size.</div></div><div><h3>Results</h3><div><em>:</em> Outbreaks detected via contact-based testing of staff were significantly smaller than those detected through routine staff reverse transcription polymerase chain reaction screening (adjusted relative risk [aRR]: 0.11; 95% confidence interval [CI]: 0.03-0.37). Resident mask-wearing was associated with smaller outbreak sizes (aRR: 0.40; 95% CI: 0.16-0.99). Routine screening identified only 16.7% of staff index cases despite being widely implemented, suggesting limitations in effectiveness.</div></div><div><h3>Conclusions</h3><div><em>:</em> Risk-based, exposure-driven testing appears markedly more effective than fixed-interval screening for limiting outbreak size in residential facilities for the elderly. Implementation should consider both operational feasibility and support systems for frontline staff.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100813"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145790859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Agreement and systematic bias between QuantiFERON chemiluminescent immunoassay and QuantiFERON enzyme-linked immunosorbent assay in the detection of latent tuberculosis infection: A systematic review and meta-analysis QuantiFERON化学发光免疫分析法和QuantiFERON酶联免疫吸附法检测潜伏性结核感染的一致性和系统偏倚:一项系统综述和荟萃分析
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-12-07 DOI: 10.1016/j.ijregi.2025.100824
Felix Bongomin , Ivaan Pitua , Phillip Ssekamatte , Diana Sitenda , Irene Andia-Biraro , Bwambale Jonani
Objectives: Enzyme-linked immunosorbent assay (ELISA)–based QuantiFERON-TB Gold Plus (QFT-Plus ELISA) testing is associated with manual variability and indeterminate results. The transition from QFT-Plus ELISA to chemiluminescent immunoassay (CLIA) for QuantiFERON-TB Gold Plus (QFT-Plus CLIA) testing represents a significant methodological evolution that requires comprehensive evaluation. This systematic review and meta-analysis aimed to assess method agreement, characterize systematic bias patterns, evaluate clinical concordance between DiaSorin's QFT-Plus CLIA and QIAGEN's (QFT-Plus ELISA) methodologies, and determine sources of heterogeneity across diverse populations for latent tuberculosis infection (LTBI) detection.
Methods: We searched the PubMed, Embase, and Google Scholar databases from January 2019 to January 2025 for studies comparing QFT-Plus CLIA and QFT-Plus ELISA methodologies for LTBI detection. Two reviewers independently screened the studies and assessed their quality using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool. We conducted a meta-analysis of agreement measures using random-effects models, systematic bias characterization, meta-regression analysis of the sources of heterogeneity, and clinical subgroup analysis. Evidence certainty was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE). The review was registered with PROSPERO (CRD420251031884).
Results: A total of 16 studies comprising 4169 participants were included. A meta-analysis of 10 studies (n = 2932) revealed a substantial overall concordance of 88.76% (95% confidence interval [CI] 83.57-93.95). Among the seven studies with complete data to calculate positive and negative agreement measures (n = 1305), the pooled positive agreement was 91.3% (95% CI 88.95-93.65) and the negative agreement was 93.89% (95% CI 92.18-95.6). The comparative analysis revealed a mean discordance rate of 6.56% (range: 0.44-16.67%), with a weighted mean directional bias of +0.2% (showing minimal overall directional preference between platforms). Significant heterogeneity was observed (I² = 95.8%, P <0.0001), and evidence certainty was rated “very low” due to methodological limitations.
Conclusions: Diasorin's QFT-Plus CLIA and QIAGEN's QFT-Plus ELISA demonstrated substantial overall agreement in detecting LTBI, with the strongest concordance for clearly positive and negative results. Laboratories implementing QFT-Plus CLIA platforms should consider verification studies, and future research should evaluate the clinical significance of discordant results and optimize interpretive algorithms for diverse epidemiologic settings.
目的:基于酶联免疫吸附试验(ELISA)的QuantiFERON-TB Gold Plus (QFT-Plus ELISA)检测与人工变异和不确定结果相关。QuantiFERON-TB Gold Plus (QFT-Plus CLIA)检测从QFT-Plus ELISA到化学发光免疫分析法(CLIA)的转变代表了一种重要的方法学进化,需要进行全面的评估。本系统综述和荟萃分析旨在评估方法的一致性,表征系统偏倚模式,评估DiaSorin的QFT-Plus CLIA和QIAGEN的QFT-Plus ELISA方法之间的临床一致性,并确定不同人群中潜伏性结核感染(LTBI)检测的异质性来源。方法:我们检索了2019年1月至2025年1月的PubMed、Embase和谷歌Scholar数据库,以比较QFT-Plus CLIA和QFT-Plus ELISA方法检测LTBI的研究。两名审稿人独立筛选研究并使用诊断准确性研究质量评估2 (QUADAS-2)工具评估其质量。我们使用随机效应模型、系统偏倚表征、异质性来源的元回归分析和临床亚组分析对一致性测量进行了荟萃分析。证据确定性采用推荐、评估、发展和评价分级(GRADE)进行评估。该综述已在PROSPERO注册(CRD420251031884)。结果:共纳入16项研究,4169名受试者。10项研究(n = 2932)的荟萃分析显示,总体一致性为88.76%(95%可信区间[CI] 83.57-93.95)。在有完整资料计算阳性和阴性一致性测度的7项研究(n = 1305)中,阳性一致性为91.3% (95% CI 88.95-93.65),阴性一致性为93.89% (95% CI 92.18-95.6)。对比分析显示,平均不一致率为6.56%(范围:0.44-16.67%),加权平均方向偏差为+0.2%(平台之间的总体方向偏好最小)。观察到显著的异质性(I²= 95.8%,P <0.0001),由于方法学的限制,证据确定性被评为“非常低”。结论:Diasorin的QFT-Plus CLIA和QIAGEN的QFT-Plus ELISA在检测LTBI方面显示出大量的总体一致性,在明确的阳性和阴性结果方面具有最强的一致性。实施QFT-Plus CLIA平台的实验室应考虑验证研究,未来的研究应评估不一致结果的临床意义,并优化不同流行病学背景下的解释算法。
{"title":"Agreement and systematic bias between QuantiFERON chemiluminescent immunoassay and QuantiFERON enzyme-linked immunosorbent assay in the detection of latent tuberculosis infection: A systematic review and meta-analysis","authors":"Felix Bongomin ,&nbsp;Ivaan Pitua ,&nbsp;Phillip Ssekamatte ,&nbsp;Diana Sitenda ,&nbsp;Irene Andia-Biraro ,&nbsp;Bwambale Jonani","doi":"10.1016/j.ijregi.2025.100824","DOIUrl":"10.1016/j.ijregi.2025.100824","url":null,"abstract":"<div><div>Objectives: Enzyme-linked immunosorbent assay (ELISA)–based QuantiFERON-TB Gold Plus (QFT-Plus ELISA) testing is associated with manual variability and indeterminate results. The transition from QFT-Plus ELISA to chemiluminescent immunoassay (CLIA) for QuantiFERON-TB Gold Plus (QFT-Plus CLIA) testing represents a significant methodological evolution that requires comprehensive evaluation. This systematic review and meta-analysis aimed to assess method agreement, characterize systematic bias patterns, evaluate clinical concordance between DiaSorin's QFT-Plus CLIA and QIAGEN's (QFT-Plus ELISA) methodologies, and determine sources of heterogeneity across diverse populations for latent tuberculosis infection (LTBI) detection.</div><div>Methods: We searched the PubMed, Embase, and Google Scholar databases from January 2019 to January 2025 for studies comparing QFT-Plus CLIA and QFT-Plus ELISA methodologies for LTBI detection. Two reviewers independently screened the studies and assessed their quality using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool. We conducted a meta-analysis of agreement measures using random-effects models, systematic bias characterization, meta-regression analysis of the sources of heterogeneity, and clinical subgroup analysis. Evidence certainty was assessed using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE). The review was registered with PROSPERO (CRD420251031884).</div><div>Results: A total of 16 studies comprising 4169 participants were included. A meta-analysis of 10 studies (n = 2932) revealed a substantial overall concordance of 88.76% (95% confidence interval [CI] 83.57-93.95). Among the seven studies with complete data to calculate positive and negative agreement measures (n = 1305), the pooled positive agreement was 91.3% (95% CI 88.95-93.65) and the negative agreement was 93.89% (95% CI 92.18-95.6). The comparative analysis revealed a mean discordance rate of 6.56% (range: 0.44-16.67%), with a weighted mean directional bias of +0.2% (showing minimal overall directional preference between platforms). Significant heterogeneity was observed (I² = 95.8%, <em>P</em> &lt;0.0001), and evidence certainty was rated “very low” due to methodological limitations.</div><div>Conclusions: Diasorin's QFT-Plus CLIA and QIAGEN's QFT-Plus ELISA demonstrated substantial overall agreement in detecting LTBI, with the strongest concordance for clearly positive and negative results. Laboratories implementing QFT-Plus CLIA platforms should consider verification studies, and future research should evaluate the clinical significance of discordant results and optimize interpretive algorithms for diverse epidemiologic settings.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100824"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145925890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to ‘Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study’ [IJID Regions, volume 17 (2025) 100786] “在先前接种过两剂COVISHIELD™或COVAXIN疫苗的成年志愿者中,作为异源加强剂的CORBEVAX™疫苗的免疫原性和安全性:一项前瞻性双盲随机III期临床研究”的勘误表[IJID Regions, volume 17 (2025) 100786]
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-01-02 DOI: 10.1016/j.ijregi.2025.100831
Subhash Thuluva , Vikram Paradkar , SubbaReddy Gunneri , Vijay Yerroju , Rammohan Reddy Mogulla , Kamal Thammireddy , Siddalingaiah Ningaiah , Chirag Dhar , Akshay Binayke , Aymaan Zaheer , Amit Awasthi , Shiva Narang , Naveen Chander Reddy , Anil Kumar Pandey , Chitta Sitaram Anjaneylu
{"title":"Corrigendum to ‘Immunogenicity and safety of Biological E’s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study’ [IJID Regions, volume 17 (2025) 100786]","authors":"Subhash Thuluva ,&nbsp;Vikram Paradkar ,&nbsp;SubbaReddy Gunneri ,&nbsp;Vijay Yerroju ,&nbsp;Rammohan Reddy Mogulla ,&nbsp;Kamal Thammireddy ,&nbsp;Siddalingaiah Ningaiah ,&nbsp;Chirag Dhar ,&nbsp;Akshay Binayke ,&nbsp;Aymaan Zaheer ,&nbsp;Amit Awasthi ,&nbsp;Shiva Narang ,&nbsp;Naveen Chander Reddy ,&nbsp;Anil Kumar Pandey ,&nbsp;Chitta Sitaram Anjaneylu","doi":"10.1016/j.ijregi.2025.100831","DOIUrl":"10.1016/j.ijregi.2025.100831","url":null,"abstract":"","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100831"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145883957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Carriage of multidrug-resistant bacteria and encoding genes among Vietnamese children with acute diarrhea 越南急性腹泻患儿多重耐药菌及其编码基因的携带
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-01-12 DOI: 10.1016/j.ijregi.2026.100844
Xuan Duong Tran , Thi Loi Dao , Ndiaw Goumballa , Trong Kiem Tran , Thanh Binh Nguyen , Duy Cuong Nguyen , Pierre Marty , Philippe Gautret

Objectives

This study aimed to assess the prevalence of multidrug-resistant (MDR) bacterial carriage and resistance-encoding genes in children with acute diarrhea.

Methods

A prospective study was conducted from July 2020 to July 2021 in hospitalized children aged under 5 years. Stool samples were collected at hospital admission. MDR bacteria were identified by culture, antimicrobial susceptibility patterns were assessed using the disk diffusion method, and resistance genes were investigated in isolates, using real-time polymerase chain reaction. Colistin resistance genes were also tested from stool samples.

Results

A total of 451 children were included; 33.2% harbored at least one MDR bacteria and/or one colistin resistance genes. A total of 79 (17.6%) children were positive for at least one MDR pathogen by culture. A total of 100 isolates were identified, including 17 methicillin-resistant Staphylococcus aureus and 83 Enterobacteriaceae. Escherichia coli was the most common (11.8%), followed by S. aureus (3.8%) and Klebsiella pneumoniae (2.7%). High resistance levels were observed in tested isolates: 94.8% to ceftriaxone, 77.1% to cefepime, 42.2% to piperacillin–tazobactam, and 19.3% to ertapenem. Among methicillin-resistant S. aureus isolates, 15 of 17 (88.2%) carried the mecA gene. Among Enterobacteriaceae, 73/83 (88.0%) carried blaCTX-M-A, 49 (59.0%) had blaTEM, 19 (22.9%) had blaSHV, and six (7.2%) were positive for blaNDM. In addition, 87 (19.3%) of 451 children carried at least one colistin resistance gene, with 10.9% of mcr-1.

Conclusions

MDR bacterial carriage and resistance genes were frequently detected at hospital admission, reflecting community or previous health care–associated exposure rather than in-hospital antibiotic selection. These findings underscore the urgent need for strengthened antimicrobial stewardship, rational antibiotic use, improved infection control, and enhanced diagnostic capacity.
目的研究急性腹泻患儿多药耐药(MDR)细菌携带及耐药编码基因的流行情况。方法对2020年7月至2021年7月住院的5岁以下儿童进行前瞻性研究。入院时收集粪便样本。采用培养法鉴定耐多药耐多药菌,采用纸片扩散法评估耐药模式,采用实时聚合酶链反应(pcr)检测菌株耐药基因。还从粪便样本中检测了粘菌素抗性基因。结果共纳入451例儿童;33.2%的人至少携带一种耐多药细菌和/或一种粘菌素耐药基因。共有79例(17.6%)儿童培养出至少一种耐多药病原菌阳性。共分离到100株,其中耐甲氧西林金黄色葡萄球菌17株,肠杆菌科83株。最常见的是大肠杆菌(11.8%),其次是金黄色葡萄球菌(3.8%)和肺炎克雷伯菌(2.7%)。对头孢曲松耐药94.8%,对头孢吡肟耐药77.1%,对哌拉西林-他唑巴坦耐药42.2%,对厄他培南耐药19.3%。耐甲氧西林金黄色葡萄球菌17株中有15株(88.2%)携带mecA基因。肠杆菌科细菌中blaCTX-M-A阳性73/83例(88.0%),blem阳性49例(59.0%),blaSHV阳性19例(22.9%),blaNDM阳性6例(7.2%)。此外,451名儿童中有87名(19.3%)携带至少一种粘菌素耐药基因,其中mcr-1占10.9%。结论smdr细菌携带和耐药基因常见于住院患者,反映的是社区或既往卫生保健相关暴露,而非院内抗生素选择。这些发现强调了加强抗菌药物管理、合理使用抗生素、改善感染控制和提高诊断能力的迫切需要。
{"title":"Carriage of multidrug-resistant bacteria and encoding genes among Vietnamese children with acute diarrhea","authors":"Xuan Duong Tran ,&nbsp;Thi Loi Dao ,&nbsp;Ndiaw Goumballa ,&nbsp;Trong Kiem Tran ,&nbsp;Thanh Binh Nguyen ,&nbsp;Duy Cuong Nguyen ,&nbsp;Pierre Marty ,&nbsp;Philippe Gautret","doi":"10.1016/j.ijregi.2026.100844","DOIUrl":"10.1016/j.ijregi.2026.100844","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to assess the prevalence of multidrug-resistant (MDR) bacterial carriage and resistance-encoding genes in children with acute diarrhea.</div></div><div><h3>Methods</h3><div>A prospective study was conducted from July 2020 to July 2021 in hospitalized children aged under 5 years. Stool samples were collected at hospital admission. MDR bacteria were identified by culture, antimicrobial susceptibility patterns were assessed using the disk diffusion method, and resistance genes were investigated in isolates, using real-time polymerase chain reaction. Colistin resistance genes were also tested from stool samples.</div></div><div><h3>Results</h3><div>A total of 451 children were included; 33.2% harbored at least one MDR bacteria and/or one colistin resistance genes. A total of 79 (17.6%) children were positive for at least one MDR pathogen by culture. A total of 100 isolates were identified, including 17 methicillin-resistant <em>Staphylococcus aureus</em> and 83 Enterobacteriaceae. <em>Escherichia coli</em> was the most common (11.8%), followed by <em>S. aureus</em> (3.8%) and <em>Klebsiella pneumoniae</em> (2.7%). High resistance levels were observed in tested isolates: 94.8% to ceftriaxone, 77.1% to cefepime, 42.2% to piperacillin–tazobactam, and 19.3% to ertapenem. Among methicillin-resistant <em>S. aureus</em> isolates, 15 of 17 (88.2%) carried the <em>mecA</em> gene. Among Enterobacteriaceae, 73/83 (88.0%) carried <em>bla<sub>CTX-M-A</sub></em>, 49 (59.0%) had <em>bla<sub>TEM</sub></em>, 19 (22.9%) had <em>bla<sub>SHV</sub></em>, and six (7.2%) were positive for <em>bla<sub>NDM</sub></em>. In addition, 87 (19.3%) of 451 children carried at least one colistin resistance gene, with 10.9% of <em>mcr-1</em>.</div></div><div><h3>Conclusions</h3><div>MDR bacterial carriage and resistance genes were frequently detected at hospital admission, reflecting community or previous health care–associated exposure rather than in-hospital antibiotic selection. These findings underscore the urgent need for strengthened antimicrobial stewardship, rational antibiotic use, improved infection control, and enhanced diagnostic capacity.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100844"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Extensively drug-resistant tuberculosis in Togo: first reported cases and implications for tuberculosis control 多哥广泛耐药结核病:首次报告病例及其对结核病控制的影响
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-12-17 DOI: 10.1016/j.ijregi.2025.100825
Maïssala Zoutené , Akouvi Mawussé Edjodjinam Ako , Koffi Atsu Aziagbe , Narcisse Viani Gateu Tadjom , Tété Amento Stéphane Adambounou , Komi Séraphin Adjoh

Objectives

The increasing burden of extensively drug-resistant tuberculosis (XDR-TB) undermines global TB control efforts.

Methods

This was a case series study conducted from January 1, 2007, to December 31, 2024, in the Department of Pulmonology at Sylvanus Olympio University Teaching Hospital.

Results

We report a series of three cases. Case 1: A 30-year-old man with a history of contact with an XDR-TB case was treated with a 20-month regimen. Culture conversion was achieved at the 3rd month of treatment. A complication in the form of pyopneumothorax occurred during the 6th month of therapy. Case 2: A 51-year-old patient with no significant medical history was diagnosed with XDR-TB after 4 months of treatment for multidrug-resistant TB (MDR-TB). Conversion of follow-up cultures was achieved 2 months after modification of the treatment regimen. Case 3: A 62-year-old woman living with human immunodeficiency virus (HIV), previously treated for MDR-TB, developed XDR-TB during the course of treatment. The patient died on the 29th day of XDR-TB treatment.

Conclusions

XDR-TB is a curable disease. Early and accurate diagnosis allows for better selection of the most appropriate treatment strategy.
广泛耐药结核病(XDR-TB)负担的日益加重破坏了全球结核病控制工作。方法对2007年1月1日至2024年12月31日在希尔瓦纳斯奥林匹奥大学教学医院肺内科进行的病例系列研究。结果我们报告了三个系列病例。病例1:一名与广泛耐药结核病例有接触史的30岁男子接受了为期20个月的治疗方案。治疗第3个月实现培养转化。治疗第6个月出现气胸并发症。病例2:一名没有明显病史的51岁患者在接受耐多药结核病(MDR-TB)治疗4个月后被诊断为广泛耐药结核病。在修改治疗方案2个月后实现了随访培养的转化。病例3:一名感染人类免疫缺陷病毒(HIV)的62岁妇女,此前曾接受耐多药结核病治疗,在治疗过程中出现广泛耐药结核病。患者在广泛耐药结核治疗的第29天死亡。结论耐药结核病是一种可治愈的疾病。早期和准确的诊断可以更好地选择最合适的治疗策略。
{"title":"Extensively drug-resistant tuberculosis in Togo: first reported cases and implications for tuberculosis control","authors":"Maïssala Zoutené ,&nbsp;Akouvi Mawussé Edjodjinam Ako ,&nbsp;Koffi Atsu Aziagbe ,&nbsp;Narcisse Viani Gateu Tadjom ,&nbsp;Tété Amento Stéphane Adambounou ,&nbsp;Komi Séraphin Adjoh","doi":"10.1016/j.ijregi.2025.100825","DOIUrl":"10.1016/j.ijregi.2025.100825","url":null,"abstract":"<div><h3>Objectives</h3><div>The increasing burden of extensively drug-resistant tuberculosis (XDR-TB) undermines global TB control efforts.</div></div><div><h3>Methods</h3><div>This was a case series study conducted from January 1, 2007, to December 31, 2024, in the Department of Pulmonology at Sylvanus Olympio University Teaching Hospital.</div></div><div><h3>Results</h3><div>We report a series of three cases. Case 1: A 30-year-old man with a history of contact with an XDR-TB case was treated with a 20-month regimen. Culture conversion was achieved at the 3<sup>rd</sup> month of treatment. A complication in the form of pyopneumothorax occurred during the 6<sup>th</sup> month of therapy. Case 2: A 51-year-old patient with no significant medical history was diagnosed with XDR-TB after 4 months of treatment for multidrug-resistant TB (MDR-TB). Conversion of follow-up cultures was achieved 2 months after modification of the treatment regimen. Case 3: A 62-year-old woman living with human immunodeficiency virus (HIV), previously treated for MDR-TB, developed XDR-TB during the course of treatment. The patient died on the 29th day of XDR-TB treatment.</div></div><div><h3>Conclusions</h3><div>XDR-TB is a curable disease. Early and accurate diagnosis allows for better selection of the most appropriate treatment strategy.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100825"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health care worker–reported barriers and potential facilitators of acute lower respiratory infection care deliver for children at Mchinji District Hospital in Malawi 马拉维Mchinji地区医院卫生保健工作者报告的急性下呼吸道感染护理的障碍和潜在促进因素
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-01-18 DOI: 10.1016/j.ijregi.2026.100848
Shubhada Hooli , Beatwil Zadutsa , Everlisto Phiri , Karina Hofstee , Nichole Davis , Eric D. McCollum , Charles Makwenda , Carina King

Objectives

We sought to understand barriers to high-quality hospital-based child acute lower respiratory infection (ALRI) care at Mchinji District Hospital in Malawi.

Methods

In 2020, we conducted focus group discussions (FGDs) with clinical officers (COs) who provided direct clinical care after a half-day refresher course on pediatric ALRI case management. The underpinning research methodology of the FGDs was phenomenology, and they were analyzed using inductive and deductive thematic analysis.

Results

We recruited 16 COs to participate in three FGDs. Five themes emerged: lack of confidence in ALRI diagnosis and management, high clinical burden with understaffing, dysfunctional team dynamics, limited physical resources, and the recognition of the importance of vital sign measurements despite barriers to practice.

Conclusions

COs shared several barriers and potential interventions to improve child ALRI care delivery. Some solutions were locally implementable, with minimal to modest cost, such as a program for continuing education, standard operating procedures during electricity outages, and posting of job aides. However, many of their suggestions require investments and commitment from the Malawian Ministry of Health to increase staffing capacity and improve the physical infrastructure and are, therefore, of undetermined feasibility. Future research should examine the impact of hospital layout and infrastructure, continuing education programs, and informal vital sign assistants on clinical care delivery.
目的:我们试图了解马拉维Mchinji地区医院高质量儿童急性下呼吸道感染(ALRI)医院护理的障碍。方法在2020年,我们与提供直接临床护理的临床官员(co)在为期半天的儿科ALRI病例管理复习课程后进行焦点小组讨论(fgd)。fgd的基础研究方法是现象学,并使用归纳和演绎主题分析来分析它们。结果我们招募了16名COs参加3个fgd。出现了五个主题:对ALRI诊断和管理缺乏信心,人员不足造成的高临床负担,功能失调的团队动态,有限的物理资源,以及尽管在实践中存在障碍,但仍认识到生命体征测量的重要性。结论sco在改善儿童ALRI护理方面存在一些障碍和潜在的干预措施。一些解决方案可以在当地实施,成本最低或适中,例如继续教育计划,停电期间的标准操作程序,以及发布工作助手。然而,他们的许多建议需要马拉维卫生部的投资和承诺,以增加人员配备能力和改善有形基础设施,因此不确定可行性。未来的研究应检查医院布局和基础设施、继续教育计划和非正式生命体征助理对临床护理提供的影响。
{"title":"Health care worker–reported barriers and potential facilitators of acute lower respiratory infection care deliver for children at Mchinji District Hospital in Malawi","authors":"Shubhada Hooli ,&nbsp;Beatwil Zadutsa ,&nbsp;Everlisto Phiri ,&nbsp;Karina Hofstee ,&nbsp;Nichole Davis ,&nbsp;Eric D. McCollum ,&nbsp;Charles Makwenda ,&nbsp;Carina King","doi":"10.1016/j.ijregi.2026.100848","DOIUrl":"10.1016/j.ijregi.2026.100848","url":null,"abstract":"<div><h3>Objectives</h3><div>We sought to understand barriers to high-quality hospital-based child acute lower respiratory infection (ALRI) care at Mchinji District Hospital in Malawi.</div></div><div><h3>Methods</h3><div>In 2020, we conducted focus group discussions (FGDs) with clinical officers (COs) who provided direct clinical care after a half-day refresher course on pediatric ALRI case management. The underpinning research methodology of the FGDs was phenomenology, and they were analyzed using inductive and deductive thematic analysis.</div></div><div><h3>Results</h3><div>We recruited 16 COs to participate in three FGDs. Five themes emerged: lack of confidence in ALRI diagnosis and management, high clinical burden with understaffing, dysfunctional team dynamics, limited physical resources, and the recognition of the importance of vital sign measurements despite barriers to practice.</div></div><div><h3>Conclusions</h3><div>COs shared several barriers and potential interventions to improve child ALRI care delivery. Some solutions were locally implementable, with minimal to modest cost, such as a program for continuing education, standard operating procedures during electricity outages, and posting of job aides. However, many of their suggestions require investments and commitment from the Malawian Ministry of Health to increase staffing capacity and improve the physical infrastructure and are, therefore, of undetermined feasibility. Future research should examine the impact of hospital layout and infrastructure, continuing education programs, and informal vital sign assistants on clinical care delivery.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100848"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146173552","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cystic echinococcosis in patients with leukemia: Clinical challenges and review of reported cases 白血病患者的囊性包虫病:临床挑战和报告病例的回顾
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2026-01-08 DOI: 10.1016/j.ijregi.2026.100840
Karel Santamaria-Leandro , Bruno Guerrero-Arismendiz , César Castro-Prado , Giancarlo Pérez-Lazo , Wilmer Silva-Caso

Objectives

Cystic echinococcosis (CE) rarely coexists with hematologic malignancies. We report two Peruvian men with leukemia and CE.

Case report

One patient had chronic lymphocytic leukemia and a hepatic CE2 cyst managed with albendazole and surgery before chemoimmunotherapy, and another patient had B-cell acute lymphoblastic leukemia and prior hepatic and pulmonary CE treated with concurrent albendazole and induction chemotherapy. Both patients lived in endemic highland areas and had childhood exposure to dogs.

Discussion

A literature review identified only a few cases, mostly acute myeloid leukemia, and none from Latin America.

Conclusion

These cases highlight therapeutic dilemmas in balancing infection control and malignancy treatment, underscoring the need for tailored management strategies in endemic regions.
目的囊性包虫病(CE)很少与血液系统恶性肿瘤共存。我们报告两名秘鲁男性患有白血病和CE。病例报告:1例患者患有慢性淋巴细胞白血病和肝CE2囊肿,化疗前采用阿苯达唑和手术治疗,另1例患者患有b细胞急性淋巴细胞白血病,既往肝和肺CE,同时采用阿苯达唑和诱导化疗。这两名患者都生活在流行的高地地区,童年时与狗有过接触。一篇文献综述只发现了少数病例,大多数是急性髓系白血病,没有一例来自拉丁美洲。结论这些病例突出了在平衡感染控制和恶性肿瘤治疗方面的治疗困境,强调了在流行地区制定有针对性的管理策略的必要性。
{"title":"Cystic echinococcosis in patients with leukemia: Clinical challenges and review of reported cases","authors":"Karel Santamaria-Leandro ,&nbsp;Bruno Guerrero-Arismendiz ,&nbsp;César Castro-Prado ,&nbsp;Giancarlo Pérez-Lazo ,&nbsp;Wilmer Silva-Caso","doi":"10.1016/j.ijregi.2026.100840","DOIUrl":"10.1016/j.ijregi.2026.100840","url":null,"abstract":"<div><h3>Objectives</h3><div>Cystic echinococcosis (CE) rarely coexists with hematologic malignancies. We report two Peruvian men with leukemia and CE.</div></div><div><h3>Case report</h3><div>One patient had chronic lymphocytic leukemia and a hepatic CE2 cyst managed with albendazole and surgery before chemoimmunotherapy, and another patient had B-cell acute lymphoblastic leukemia and prior hepatic and pulmonary CE treated with concurrent albendazole and induction chemotherapy. Both patients lived in endemic highland areas and had childhood exposure to dogs.</div></div><div><h3>Discussion</h3><div>A literature review identified only a few cases, mostly acute myeloid leukemia, and none from Latin America.</div></div><div><h3>Conclusion</h3><div>These cases highlight therapeutic dilemmas in balancing infection control and malignancy treatment, underscoring the need for tailored management strategies in endemic regions.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100840"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146022411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Atypical ocular bartonellosis: A case report 非典型眼巴尔通体病1例
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-12-20 DOI: 10.1016/j.ijregi.2025.100830
Kamena Mwana-Yile HASSAN , Fatima IHBIBANE , Mathilde OTSASSO , Latifa MARIH

Objectives

To report a case of chorioretinitis without papilledema caused by Bartonella henselae in an immunocompetent patient.

Observations

A 27-year-old female patient with a history of multiple cat scratches presented on August 28, 2025, with a gradual decline in visual acuity in her right eye. This decline had been developing for 3 weeks following scratches from cats and was accompanied by a fever of 39°C. Optical coherence tomography revealed serous retinal detachment with associated epithelial detachment. Fluorescein angiography showed a hyperfluorescent perimacular focus in the superior temporal region, consistent with chorioretinitis characterized by star-shaped macular exudates, and there was no evidence of papilledema. HIV-1 and 2 serology was negative. Serum protein electrophoresis returned normal results, and the HbA1c level was 5.5%. Serology for B. henselae was positive (immunoglobulin [Ig]G and IgM) with titers greater than 1:1280 and 1:1200. The treatment plan included doxycycline (100 mg every 12 hours) for 6 weeks and rifampicin (300 mg every 12 hours) with corticosteroid therapy (1 mg/kg) for 4 weeks. Fluorescein angiography conducted 6 weeks after treatment showed a hypofluorescent area in the superior temporal region of the macula, indicating that the star-shaped macular exudates had disappeared. The patient reported improved visual acuity, although they experienced slight blurred vision in the right eye.

Conclusions

Ocular bartonellosis can lead to unusual eye damage, specifically chorioretinitis, even in the absence of papilledema.
目的报告1例免疫功能正常的母鸡巴尔通体引起的无乳头水肿的绒毛膜视网膜炎。患者女27岁,于2025年8月28日就诊,有多处猫抓伤史,右眼视力逐渐下降。在被猫抓伤后3周出现这种症状,并伴有39°C的发烧。光学相干断层扫描显示浆液性视网膜脱离伴相关上皮脱离。荧光素血管造影显示颞上区黄斑周围高荧光灶,符合以星形黄斑渗出物为特征的绒毛膜视网膜炎,未见乳头水肿。HIV-1、2血清学均为阴性。血清蛋白电泳正常,HbA1c水平5.5%。鸡selae B.血清免疫球蛋白G和IgM阳性,滴度分别大于1:1280和1:12 200。治疗方案包括强力霉素(100 mg/ 12小时)6周,利福平(300 mg/ 12小时)联合皮质类固醇治疗(1 mg/kg) 4周。治疗6周后荧光素血管造影显示黄斑颞上区低荧光区,表明星形黄斑渗出物消失。患者报告视力有所改善,但右眼视力略有模糊。结论即使在没有乳头水肿的情况下,眼巴尔通体病也可导致不寻常的眼部损伤,特别是绒毛膜视网膜炎。
{"title":"Atypical ocular bartonellosis: A case report","authors":"Kamena Mwana-Yile HASSAN ,&nbsp;Fatima IHBIBANE ,&nbsp;Mathilde OTSASSO ,&nbsp;Latifa MARIH","doi":"10.1016/j.ijregi.2025.100830","DOIUrl":"10.1016/j.ijregi.2025.100830","url":null,"abstract":"<div><h3>Objectives</h3><div>To report a case of chorioretinitis without papilledema caused by <em>Bartonella henselae</em> in an immunocompetent patient.</div></div><div><h3>Observations</h3><div>A 27-year-old female patient with a history of multiple cat scratches presented on August 28, 2025, with a gradual decline in visual acuity in her right eye. This decline had been developing for 3 weeks following scratches from cats and was accompanied by a fever of 39°C. Optical coherence tomography revealed serous retinal detachment with associated epithelial detachment. Fluorescein angiography showed a hyperfluorescent perimacular focus in the superior temporal region, consistent with chorioretinitis characterized by star-shaped macular exudates, and there was no evidence of papilledema. HIV-1 and 2 serology was negative. Serum protein electrophoresis returned normal results, and the HbA1c level was 5.5%. Serology for <em>B. henselae</em> was positive (immunoglobulin [Ig]G and IgM) with titers greater than 1:1280 and 1:1200. The treatment plan included doxycycline (100 mg every 12 hours) for 6 weeks and rifampicin (300 mg every 12 hours) with corticosteroid therapy (1 mg/kg) for 4 weeks. Fluorescein angiography conducted 6 weeks after treatment showed a hypofluorescent area in the superior temporal region of the macula, indicating that the star-shaped macular exudates had disappeared. The patient reported improved visual acuity, although they experienced slight blurred vision in the right eye.</div></div><div><h3>Conclusions</h3><div>Ocular bartonellosis can lead to unusual eye damage, specifically chorioretinitis, even in the absence of papilledema.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100830"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Update on the HDV seroprevalence and genotype distribution among patients positive for HBsAg referred to a National Reference Laboratory in Cameroon between January 2019 and December 2020 2019年1月至2020年12月期间向喀麦隆国家参考实验室提交的HBsAg阳性患者中HDV血清阳性率和基因型分布的最新情况
IF 1.7 Q4 INFECTIOUS DISEASES Pub Date : 2026-03-01 Epub Date: 2025-12-24 DOI: 10.1016/j.ijregi.2025.100834
Jacques Delors Toumansie Mfonkou , Yacouba Foupouapouognigni , Athenais Gerber , Ségolène Brichler , Frédéric Legal , Abdou Fatawou Modiyinji , Frederic Lissock , Laure Ngono , Boyomo Onana , Emmanuel Gordien , Richard Njouom

Objectives

Cameroon is known to be endemic for hepatitis B virus infection, but available data on hepatitis delta virus (HDV) prevalence and genetic diversity are limited, inconsistent, and outdated. This study aimed to assess the current HDV prevalence and determine the HDV genotype distribution among patients positive for hepatitis B surface antigen (HBsAg) in Cameroon.

Methods

This cross-sectional study examined patients positive for HBsAg from Cameroon’s 10 administrative regions. Anti-HDV antibodies and HDV viral load (VL) were tested using validated commercial enzyme-linked immunosorbent assay and HDV VL quantification assays. HDV genotypes were determined by the Sanger sequencing method, followed by phylogenetic analysis of the “HDV R0” genome region previously described.

Results

Of the 859 patients positive for HBsAg tested, 142 (16.5%) tested positive for anti-HDV, and HDV RNA was detected in 110 (77.5%) of them. The southern region of Cameroon had the highest infection rate. Notably, an undetectable hepatitis B virus VL was significantly associated with HDV infection (P <0.001). Patients younger than 15 years were the least infected (10%). Five genotypes—HDV-1 (the more prevalent, 83.6%), HDV-5, HDV-6, HDV-7, and HDV-8—were found in the studied population.

Conclusions

Cameroon remains an endemic country for HDV, exhibiting high prevalence, remarkable regional distribution, and wide genetic diversity.
目的已知喀麦隆是乙型肝炎病毒感染的地方,但有关丁型肝炎病毒(HDV)流行率和遗传多样性的现有数据有限、不一致且过时。本研究旨在评估目前喀麦隆乙型肝炎表面抗原(HBsAg)阳性患者中HDV的流行情况,并确定HDV基因型分布。方法横断面研究调查了来自喀麦隆10个行政区的HBsAg阳性患者。采用经验证的商用酶联免疫吸附法和HDV VL定量法检测抗HDV抗体和HDV病毒载量(VL)。通过Sanger测序法确定HDV基因型,然后对先前描述的“HDV R0”基因组区域进行系统发育分析。结果859例HBsAg阳性患者中,抗HDV阳性142例(16.5%),检出HDV RNA 110例(77.5%)。喀麦隆南部地区的感染率最高。值得注意的是,无法检测到的乙型肝炎病毒VL与HDV感染显著相关(P <0.001)。15岁以下的患者感染最少(10%)。在研究人群中发现了5种基因型:hdv -1(较普遍,占83.6%)、HDV-5、HDV-6、HDV-7和hdv -8。结论喀麦隆仍然是HDV流行的国家,具有高流行率、显著的区域分布和广泛的遗传多样性。
{"title":"Update on the HDV seroprevalence and genotype distribution among patients positive for HBsAg referred to a National Reference Laboratory in Cameroon between January 2019 and December 2020","authors":"Jacques Delors Toumansie Mfonkou ,&nbsp;Yacouba Foupouapouognigni ,&nbsp;Athenais Gerber ,&nbsp;Ségolène Brichler ,&nbsp;Frédéric Legal ,&nbsp;Abdou Fatawou Modiyinji ,&nbsp;Frederic Lissock ,&nbsp;Laure Ngono ,&nbsp;Boyomo Onana ,&nbsp;Emmanuel Gordien ,&nbsp;Richard Njouom","doi":"10.1016/j.ijregi.2025.100834","DOIUrl":"10.1016/j.ijregi.2025.100834","url":null,"abstract":"<div><h3>Objectives</h3><div>Cameroon is known to be endemic for hepatitis B virus infection, but available data on hepatitis delta virus (HDV) prevalence and genetic diversity are limited, inconsistent, and outdated. This study aimed to assess the current HDV prevalence and determine the HDV genotype distribution among patients positive for hepatitis B surface antigen (HBsAg) in Cameroon.</div></div><div><h3>Methods</h3><div>This cross-sectional study examined patients positive for HBsAg from Cameroon’s 10 administrative regions. Anti-HDV antibodies and HDV viral load (VL) were tested using validated commercial enzyme-linked immunosorbent assay and HDV VL quantification assays. HDV genotypes were determined by the Sanger sequencing method, followed by phylogenetic analysis of the “HDV R0” genome region previously described.</div></div><div><h3>Results</h3><div>Of the 859 patients positive for HBsAg tested, 142 (16.5%) tested positive for anti-HDV, and HDV RNA was detected in 110 (77.5%) of them. The southern region of Cameroon had the highest infection rate. Notably, an undetectable hepatitis B virus VL was significantly associated with HDV infection (<em>P</em> &lt;0.001). Patients younger than 15 years were the least infected (10%). Five genotypes—HDV-1 (the more prevalent, 83.6%), HDV-5, HDV-6, HDV-7, and HDV-8—were found in the studied population.</div></div><div><h3>Conclusions</h3><div>Cameroon remains an endemic country for HDV, exhibiting high prevalence, remarkable regional distribution, and wide genetic diversity.</div></div>","PeriodicalId":73335,"journal":{"name":"IJID regions","volume":"18 ","pages":"Article 100834"},"PeriodicalIF":1.7,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145976570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
IJID regions
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1